Publication | Closed Access
LO3 : Safety and efficacy of the combination daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients from the french observational cohort ANRS CO22 hepather*
36
Citations
0
References
2015
Year
Viral HepatitisAntiviral TherapyHepatitisVirologyCombination Daclatasvir-sofosbuvirChronic Viral InfectionInfection ControlMedicineEpidemiology
No additional data available for this publication yet. Check back later!